Cargando…
Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567901/ https://www.ncbi.nlm.nih.gov/pubmed/37695467 http://dx.doi.org/10.1007/s12325-023-02629-4 |
| _version_ | 1785119239327186944 |
|---|---|
| author | Udeze, Chuka Evans, Kristin A. Yang, Yoojung Lillehaugen, Timothy Manjelievskaia, Janna Mujumdar, Urvi Li, Nanxin Andemariam, Biree |
| author_facet | Udeze, Chuka Evans, Kristin A. Yang, Yoojung Lillehaugen, Timothy Manjelievskaia, Janna Mujumdar, Urvi Li, Nanxin Andemariam, Biree |
| author_sort | Udeze, Chuka |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10567901 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105679012023-10-13 Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States Udeze, Chuka Evans, Kristin A. Yang, Yoojung Lillehaugen, Timothy Manjelievskaia, Janna Mujumdar, Urvi Li, Nanxin Andemariam, Biree Adv Ther Correction Springer Healthcare 2023-09-11 2023 /pmc/articles/PMC10567901/ /pubmed/37695467 http://dx.doi.org/10.1007/s12325-023-02629-4 Text en © The Author (s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Udeze, Chuka Evans, Kristin A. Yang, Yoojung Lillehaugen, Timothy Manjelievskaia, Janna Mujumdar, Urvi Li, Nanxin Andemariam, Biree Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States |
| title | Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States |
| title_full | Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States |
| title_fullStr | Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States |
| title_full_unstemmed | Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States |
| title_short | Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States |
| title_sort | correction to: economic and clinical burden of managing sickle cell disease with recurrent vaso-occlusive crises in the united states |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567901/ https://www.ncbi.nlm.nih.gov/pubmed/37695467 http://dx.doi.org/10.1007/s12325-023-02629-4 |
| work_keys_str_mv | AT udezechuka correctiontoeconomicandclinicalburdenofmanagingsicklecelldiseasewithrecurrentvasoocclusivecrisesintheunitedstates AT evanskristina correctiontoeconomicandclinicalburdenofmanagingsicklecelldiseasewithrecurrentvasoocclusivecrisesintheunitedstates AT yangyoojung correctiontoeconomicandclinicalburdenofmanagingsicklecelldiseasewithrecurrentvasoocclusivecrisesintheunitedstates AT lillehaugentimothy correctiontoeconomicandclinicalburdenofmanagingsicklecelldiseasewithrecurrentvasoocclusivecrisesintheunitedstates AT manjelievskaiajanna correctiontoeconomicandclinicalburdenofmanagingsicklecelldiseasewithrecurrentvasoocclusivecrisesintheunitedstates AT mujumdarurvi correctiontoeconomicandclinicalburdenofmanagingsicklecelldiseasewithrecurrentvasoocclusivecrisesintheunitedstates AT linanxin correctiontoeconomicandclinicalburdenofmanagingsicklecelldiseasewithrecurrentvasoocclusivecrisesintheunitedstates AT andemariambiree correctiontoeconomicandclinicalburdenofmanagingsicklecelldiseasewithrecurrentvasoocclusivecrisesintheunitedstates |